Ann: Phase II study for indication expansion of TLX250-CDx doses, page-4

Yes

Illuccix (tlx591 cdx) is for prostate cancer only as it targets a protein that’s specific to prostate cancer

CAIX is what TLX250cdx is based on for renal

But CAIX is not specific for just renal

They are exploring “CAIX expression in patients with a diverse range of solid tumours – including breast, cervix, colorectal, gastric, esophageal, head and neck, lung, ovarian, pancreatic and vulval cancers2 – for potential diagnostic and therapeutic applications.”

So you could speculate that if it’s injected into a patient with multiple cancer types - then it would look like a star burst I guess which would show the cancer everywhere

So jump on the NCCN website and search the number of people affected by the above per year. Take 5% of those people and multiply it by a $3,000 USD dose for some speculation on a market opportunity

Again, this is my interpretation and I’m not an expert here